Currency In USD
| Previous Close | 1.56 |
| Open | 1.58 |
| Day High | 1.6 |
| Day Low | 1.54 |
| 52-Week High | 2.23 |
| 52-Week Low | 1 |
| Volume | 373,828 |
| Average Volume | 920,515 |
| Market Cap | 18.02M |
| PE | -0.52 |
| EPS | -3.02 |
| Moving Average 50 Days | 1.3 |
| Moving Average 200 Days | 1.27 |
| Change | 0.01 |
Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026
GlobeNewswire Inc.
Mar 09, 2026 8:05 PM GMT
SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, March 23, 2026, at 4:30 p.m. Eastern Time to report financial results for the fourth
Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale
GlobeNewswire Inc.
Feb 27, 2026 1:00 PM GMT
SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and mo
10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders
GlobeNewswire Inc.
Feb 26, 2026 1:00 PM GMT
SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how thes